Susceptibility to infections is a common clinical symptom among CTLA4 mutation carriers, and as in the case of SLE, EBV infections or reactivations are common, leading to an increased risk of malignancy (3, 5, 18). Here, CTLA4 is linked to Epstein-Barr virus infection.